Cargando…
Alzheimer disease and platelets: how’s that relevant
Alzheimer Disease (AD) is the most common neurodegenerative disorder worldwide, and account for 60% to 70% of all cases of progressive cognitive impairment in elderly patients. At the microscopic level distinctive features of AD are neurons and synapses degeneration, together with extensive amounts...
Autores principales: | Catricala, Silvia, Torti, Mauro, Ricevuti, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545835/ https://www.ncbi.nlm.nih.gov/pubmed/22985434 http://dx.doi.org/10.1186/1742-4933-9-20 |
Ejemplares similares
-
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
por: Canobbio, Ilaria, et al.
Publicado: (2015) -
The Controversial Role of LPS in Platelet Activation In Vitro
por: Galgano, Luca, et al.
Publicado: (2022) -
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
por: Varesi, Angelica, et al.
Publicado: (2023) -
The Small GTPase Rap1b: A Bidirectional Regulator of Platelet Adhesion Receptors
por: Guidetti, Gianni Francesco, et al.
Publicado: (2012) -
Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer’s Disease and Its Neuropsychiatric Symptoms
por: Scassellati, Catia, et al.
Publicado: (2021)